• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与中线胶质母细胞瘤相比,具有H3 K27M突变的弥漫性中线胶质瘤的MRI特征和ADC值的差异。

Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas.

作者信息

Raab Peter, Banan Rouzbeh, Akbarian Arash, Esmaeilzadeh Majid, Samii Madjid, Samii Amir, Bertalanffy Helmut, Lehmann Ulrich, Krauss Joachim K, Lanfermann Heinrich, Hartmann Christian, Brüning Roland

机构信息

Institute of Diagnostic and Interventional Neuroradiology, Hannover Medical School, 30625 Hannover, Germany.

Department of Neuropathology, University of Heidelberg, 69120 Heidelberg, Germany.

出版信息

Cancers (Basel). 2022 Mar 9;14(6):1397. doi: 10.3390/cancers14061397.

DOI:10.3390/cancers14061397
PMID:35326549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8946584/
Abstract

We conducted a two-center retrospective survey on standard MRI features including apparent diffusion coefficient mapping (ADC) of diffuse midline gliomas H3 K27M-mutant (DMG) compared to midline glioblastomas H3 K27M-wildtype (midGBM-H3wt). We identified 39 intracranial DMG and 18 midGBM-H3wt tumors. Samples were microscopically re-evaluated for microvascular proliferations and necrosis. Image analysis focused on location, peritumoral edema, degree of contrast enhancement and DWI features. Within DMG, MRI features between tumors with or without histomorphological GBM features were compared. DMG occurred in 15/39 samples from the thalamus (38%), in 23/39 samples from the brainstem (59%) and in 1/39 tumors involving primarily the cerebellum (2%). Edema was present in 3/39 DMG cases (8%) versus 78% in the control (midGBM-H3wt) group (p < 0.001). Contrast enhancement at the tumor rim was detected in 17/39 DMG (44%) versus 67% in control (p = 0.155), and necrosis in 24/39 (62%) versus 89% in control (p = 0.060). Strong contrast enhancement was observed in 15/39 DMG (38%) versus 56% in control (p = 0.262). Apparent diffusion coefficient (ADC) histogram analysis showed significantly higher skewness and kurtosis values in the DMG group compared to the controls (p = 0.0016/p = 0.002). Minimum relative ADC (rADC) values, as well as the 10th and 25th rADC-percentiles, were lower in DMGs with GBM features within the DMG group (p < 0.001/p = 0.012/p = 0.027). In conclusion, DMG cases exhibited markedly less edema than midGBM-H3wt, even if histomorphological malignancy was present. Histologically malignant DMGs and midGBM-H3wt more often displayed strong enhancement, as well as rim enhancement, than DMGs without histomorphological malignancy. DMGs showed higher skewness and kurtosis values on ADC-histogram analysis compared to midGBM-H3wt. Lower minimum rADC values in DMGs indicated malignant histomorphological features, likely representing a more complex tissue microstructure.

摘要

我们进行了一项双中心回顾性研究,对比了弥漫性中线胶质瘤H3 K27M突变型(DMG)与中线胶质母细胞瘤H3 K27M野生型(midGBM - H3wt)的标准MRI特征,包括表观扩散系数图(ADC)。我们确定了39例颅内DMG肿瘤和18例midGBM - H3wt肿瘤。对样本进行显微镜下重新评估,以确定微血管增殖和坏死情况。图像分析聚焦于肿瘤位置、瘤周水肿、对比增强程度和DWI特征。在DMG组内,比较了具有或不具有组织形态学GBM特征的肿瘤之间的MRI特征。DMG发生于39例样本中的15例(38%)丘脑肿瘤、23例(59%)脑干肿瘤和1例(2%)主要累及小脑的肿瘤。39例DMG病例中有3例(8%)出现水肿,而对照组(midGBM - H3wt)为78%(p < 0.001)。39例DMG中有17例(44%)在肿瘤边缘检测到对比增强,而对照组为67%(p = 0.155);39例中有24例(62%)出现坏死,对照组为89%(p = 0.060)。39例DMG中有15例(38%)观察到强烈对比增强,对照组为5(6%)(p = 0.262)。表观扩散系数(ADC)直方图分析显示,与对照组相比,DMG组的偏度和峰度值显著更高(p = 0.0016/p = 0.002)。在DMG组中,具有GBM特征的DMG的最小相对ADC(rADC)值以及第10和第25百分位rADC值较低(p < 0.001/p = 0.012/p = 0.027)。总之,即使存在组织形态学恶性特征,DMG病例的水肿也明显少于midGBM - H3wt。与无组织形态学恶性特征的DMG相比,组织学上恶性的DMG和midGBM - H3wt更常表现出强烈增强以及边缘增强。与midGBM - H3wt相比,DMG在ADC直方图分析中显示出更高的偏度和峰度值。DMG中较低的最小rADC值表明存在恶性组织形态学特征,可能代表更复杂的组织微观结构。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/8946584/05065498d159/cancers-14-01397-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/8946584/80136e3d2b5e/cancers-14-01397-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/8946584/05065498d159/cancers-14-01397-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/8946584/80136e3d2b5e/cancers-14-01397-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/8946584/05065498d159/cancers-14-01397-g002.jpg

相似文献

1
Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas.与中线胶质母细胞瘤相比,具有H3 K27M突变的弥漫性中线胶质瘤的MRI特征和ADC值的差异。
Cancers (Basel). 2022 Mar 9;14(6):1397. doi: 10.3390/cancers14061397.
2
Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures.弥漫性中线胶质瘤,H3 K27M 突变型与弥漫性中线结构中的 H3 K27M 野生型相比,其瘤周水肿和对比增强程度较低。
PLoS One. 2021 Aug 4;16(8):e0249647. doi: 10.1371/journal.pone.0249647. eCollection 2021.
3
Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis.基于表观扩散系数直方图分析的组蛋白 H3-K27M 突变型小儿弥漫中线胶质瘤的扩散特征。
AJNR Am J Neuroradiol. 2019 Nov;40(11):1804-1810. doi: 10.3174/ajnr.A6302. Epub 2019 Nov 6.
4
Clinical, qualitative imaging biomarkers, and tumor oxygenation imaging biomarkers for differentiation of midline-located IDH wild-type glioblastomas and H3 K27-altered diffuse midline gliomas in adults.用于鉴别成人中线部位 IDH 野生型胶质母细胞瘤和 H3 K27 改变弥漫性中线胶质瘤的临床、定性成像生物标志物和肿瘤氧合成像生物标志物。
Eur J Radiol. 2024 Apr;173:111384. doi: 10.1016/j.ejrad.2024.111384. Epub 2024 Feb 18.
5
Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements.通过表观扩散系数测量无创评估弥漫性中线胶质瘤 H3 K27M 突变状态。
Eur J Radiol. 2019 May;114:152-159. doi: 10.1016/j.ejrad.2019.03.006. Epub 2019 Mar 14.
6
Diffusion and perfusion imaging biomarkers of H3 K27M mutation status in diffuse midline gliomas.弥散中线胶质瘤 H3 K27M 突变状态的扩散和灌注成像生物标志物。
Neuroradiology. 2022 Aug;64(8):1519-1528. doi: 10.1007/s00234-021-02857-x. Epub 2022 Jan 27.
7
Exploring MRI Characteristics of Brain Diffuse Midline Gliomas With the H3 K27M Mutation Using Radiomics.利用放射组学探索具有H3 K27M突变的脑弥漫性中线胶质瘤的MRI特征
Front Oncol. 2021 May 24;11:646267. doi: 10.3389/fonc.2021.646267. eCollection 2021.
8
Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance.整合分析揭示 H3 K27M 突变型弥漫性中线神经胶质瘤的两种具有预后意义的分子和临床明显不同亚型。
Acta Neuropathol. 2024 Sep 10;148(1):40. doi: 10.1007/s00401-024-02800-3.
9
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults.成人组蛋白H3 K27M突变型弥漫性中线胶质瘤的临床、影像学和遗传学特征
Neurooncol Adv. 2020 Oct 22;2(1):vdaa142. doi: 10.1093/noajnl/vdaa142. eCollection 2020 Jan-Dec.
10
Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics.成人弥漫性中线胶质瘤:临床、影像学和遗传学特征。
J Clin Neurosci. 2020 Dec;82(Pt A):1-8. doi: 10.1016/j.jocn.2020.10.005. Epub 2020 Nov 1.

引用本文的文献

1
Applications of artificial intelligence and advanced imaging in pediatric diffuse midline glioma.人工智能与先进成像技术在儿童弥漫性中线胶质瘤中的应用
Neuro Oncol. 2025 Jul 30;27(6):1419-1433. doi: 10.1093/neuonc/noaf058.
2
Advances in diffuse glioma assessment: preoperative and postoperative applications of chemical exchange saturation transfer.弥漫性胶质瘤评估的进展:化学交换饱和转移的术前和术后应用
Front Neurosci. 2024 Jul 31;18:1424316. doi: 10.3389/fnins.2024.1424316. eCollection 2024.
3
Decoding Diffuse Midline Gliomas: A Comprehensive Review of Pathogenesis, Diagnosis and Treatment.

本文引用的文献

1
MRI-based radiomics signature and clinical factor for predicting H3K27M mutation in pediatric high-grade gliomas located in the midline of the brain.基于 MRI 的放射组学特征和临床因素预测脑中线部位儿童高级别胶质瘤 H3K27M 突变。
Eur Radiol. 2022 Mar;32(3):1813-1822. doi: 10.1007/s00330-021-08234-9. Epub 2021 Oct 16.
2
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.美国 2014-2018 年诊断的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2021 Oct 5;23(12 Suppl 2):iii1-iii105. doi: 10.1093/neuonc/noab200.
3
Deep learning features from diffusion tensor imaging improve glioma stratification and identify risk groups with distinct molecular pathway activities.
解读弥漫性中线胶质瘤:发病机制、诊断与治疗的全面综述
Cancers (Basel). 2023 Oct 6;15(19):4869. doi: 10.3390/cancers15194869.
4
Classification of brain lesions using a machine learning approach with cross-sectional ADC value dynamics.基于横断面 ADC 值动态的机器学习方法对脑病变进行分类。
Sci Rep. 2023 Jul 15;13(1):11459. doi: 10.1038/s41598-023-38542-7.
5
The value of whole-volume apparent diffusion coefficient histogram analysis in preoperatively distinguishing intracranial solitary fibrous tumor and transitional meningioma.全容积表观扩散系数直方图分析在术前鉴别颅内孤立性纤维瘤和过渡型脑膜瘤中的价值
Front Oncol. 2023 May 16;13:1155162. doi: 10.3389/fonc.2023.1155162. eCollection 2023.
6
Multimodal MRI radiomic models to predict genomic mutations in diffuse intrinsic pontine glioma with missing imaging modalities.用于预测弥漫性脑桥内在型胶质瘤基因组突变的多模态MRI影像组学模型,其中存在缺失的成像模态。
Front Med (Lausanne). 2023 Feb 23;10:1071447. doi: 10.3389/fmed.2023.1071447. eCollection 2023.
基于弥散张量成像的深度学习特征可改善脑胶质瘤分级,识别具有不同分子通路活性的危险分组。
EBioMedicine. 2021 Oct;72:103583. doi: 10.1016/j.ebiom.2021.103583. Epub 2021 Sep 24.
4
Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures.弥漫性中线胶质瘤,H3 K27M 突变型与弥漫性中线结构中的 H3 K27M 野生型相比,其瘤周水肿和对比增强程度较低。
PLoS One. 2021 Aug 4;16(8):e0249647. doi: 10.1371/journal.pone.0249647. eCollection 2021.
5
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
6
Multiparametric MRI texture analysis in prediction of glioma biomarker status: added value of MR diffusion.多参数磁共振成像纹理分析在预测胶质瘤生物标志物状态中的应用:磁共振扩散的附加价值
Neurooncol Adv. 2021 Apr 8;3(1):vdab051. doi: 10.1093/noajnl/vdab051. eCollection 2021 Jan-Dec.
7
Radiogenomics of diffuse intrinsic pontine gliomas (DIPGs): correlation of histological and biological characteristics with multimodal MRI features.弥漫性内在脑桥胶质瘤(DIPG)的放射基因组学:组织学和生物学特征与多模态 MRI 特征的相关性。
Eur Radiol. 2021 Dec;31(12):8913-8924. doi: 10.1007/s00330-021-07991-x. Epub 2021 May 18.
8
Assessment of Renal Cell Carcinoma by Texture Analysis in Clinical Practice: A Six-Site, Six-Platform Analysis of Reliability.临床实践中基于纹理分析的肾细胞癌评估:六站点、六平台可靠性分析。
AJR Am J Roentgenol. 2021 Nov;217(5):1132-1140. doi: 10.2214/AJR.21.25456. Epub 2021 Apr 14.
9
Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations.在83例伴有H3F3A K27M突变的弥漫性中线胶质瘤系列病例中,FGFR1基因内的突变与较好的预后相关。
Acta Neuropathol. 2021 Feb;141(2):323-325. doi: 10.1007/s00401-020-02259-y. Epub 2021 Jan 12.
10
A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets.一项 DIPG 的初步放射基因组学研究揭示了具有独特临床轨迹和治疗靶点的不同亚组。
Acta Neuropathol Commun. 2021 Jan 11;9(1):14. doi: 10.1186/s40478-020-01107-0.